This methylation state can be used to distinguish IDH-mutant astrocytoma from other forms of diffusely infiltrating gliomas and other CNS neoplasms, and predict clinical outcomes [33, 34, 74, 108, 183, 227]. This evidence concerns the gene IDH1 and central nervous system neoplasm.